Enhancement of Spontaneous Fibrinolytic Activity in Diabetic Retinopathy

Summary The fibrinolytic system was studied in 96 patients with type I diabetes mellitus. Patients were grouped according to their degree of retinopathy; 38 patients with no evidence of retinopathy, 28 patients with background retinopathy and 30 patients with proliferative retinopathy. Thirty healthy individuals served as controls. The basal fibrinolytic activity as measured by clot lysis time and t-PA activity was increased in diabetic patients. This was associated with low levels of plasminogen activator inhibitor. Increased levels of D-dimer in diabetic patients further indicate enhanced in vivo fibrinolysis. The increase in fibrinolytic activity was highest in diabetics without retinopathy, and decreased with increasing retinopathy. Endothelial release of t-PA after venous occlusion was not different between controls and all diabetic groups. These findings suggest that in type I diabetics the fibrinolytic system is in an activated state. With worsening of retinopathy this increase in fibrinolytic activity diminishes.

[1]  E. Cagliero,et al.  Pathobiology of Endothelial and Other Vascular Cells in Diabetes Mellitus: Call for Data , 1991, Diabetes.

[2]  F. Marongiu,et al.  Is the imbalance between thrombin and plasmin activity in diabetes related to the behaviour of antiplasmin activity? , 1990, Thrombosis research.

[3]  T. Merimee,et al.  Diabetic retinopathy. A synthesis of perspectives. , 1990, The New England journal of medicine.

[4]  D. Tschoepe,et al.  Evidence for abnormal platelet glycoprotein expression in diabetes mellitus , 1990, European journal of clinical investigation.

[5]  A. Meinders,et al.  Acute exogenous hyperinsulinaemia does not result in elevation of plasma plasminogen activator inhibitor-1 (PAI-1) in humans , 1990 .

[6]  W. Mangel.  Enzyme systems. Better reception for urokinase. , 1990, Nature.

[7]  G. Lowe,et al.  Tissue Plasminogen Activator Inhibition in Diabetes Mellitus , 1989, Diabetes Care.

[8]  R. Engerman,et al.  Pathogenesis of Diabetic Retinopathy , 1989, Diabetes.

[9]  H. Niwano,et al.  Activation of blood coagulation and fibrinolysis in diabetes mellitus: evaluation by plasma levels of thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex. , 1989, Thrombosis research.

[10]  B. Feldt-Rasmussen,et al.  FEATURES OF ENDOTHELIAL DYSFUNCTION IN EARLY DIABETIC NEPHROPATHY , 1989, The Lancet.

[11]  G. Triolo,et al.  Serum Levels of Type III Procollagen Peptide in Diabetes Mellitus , 1989, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[12]  D L DeMets,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. , 1989, Archives of ophthalmology.

[13]  T. Kooistra,et al.  Insulin Stimulates the Synthesis of Plasminogen Activator Inhibitor 1 by the Human Hepatocellular Cell Line Hep G2 , 1988, Thrombosis and Haemostasis.

[14]  R. Ramsay,et al.  Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. , 1988, The New England journal of medicine.

[15]  J. Auwerx,et al.  Tissue‐Type Plasminogen Activator Antigen and Plasminogen Activator Inhibitor in Diabetes Mellitus , 1988, Arteriosclerosis.

[16]  R. Rizza,et al.  Diabetic retinopathy after two years of intensified insulin treatment. Follow-up of the Kroc Collaborative Study. The Kroc Collaborative Study Group. , 1988, JAMA.

[17]  P. Vague,et al.  Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1. , 1987, Diabete & metabolisme.

[18]  C. Kluft,et al.  Plasminogen activator inhibitors. , 1987, Blood.

[19]  B. Winblad,et al.  Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay. , 1986, Clinical chemistry.

[20]  L. Liotta,et al.  Degradation of Glycoprotein and Collagenous Components of the Basement Membrane: Studies with Urokinase-Type Plasminogen Activator, α-Thrombin, and Plasmin , 1986, Seminars in thrombosis and hemostasis.

[21]  L. Balleisen,et al.  Basement membrane components (7S collagen, laminin P1) are increased in sera of diabetics and activate platelets in vitro. , 1986, Haemostasis.

[22]  J. van de Loo,et al.  Factors of the hemostatic system in diabetic patients. A survey of controlled studies. , 1986, Haemostasis.

[23]  W. Heerde,et al.  The Effect of Diabetes Regulation on Platelet Release, Fibrinolysis and Coagulation Tests, Before and After Stimulation with DDAVP , 1985, Thrombosis and Haemostasis.

[24]  B. Lämmle,et al.  Fifteen Coagulation and Fibrinolysis Parameters in Diabetes Mellitus and in Patients with Vasculopathy , 1984, Thrombosis and Haemostasis.

[25]  J. Verheijen,et al.  Evidence for the Occurrence of a Fast-Acting Inhibitor for Tissue-Type Plasminogen Activator in Human Plasma , 1984, Thrombosis and Haemostasis.

[26]  C. Mogensen,et al.  Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. , 1984, The New England journal of medicine.

[27]  M. Packham,et al.  Platelets and diabetes mellitus. , 1977, The New England journal of medicine.

[28]  E. Mullaart,et al.  A Simple, Sensitive Spectrophotometric Assay for Extrinsic (Tissue-Type) Plasminogen Activator Applicable to Measurements in Plasma , 1982, Thrombosis and Haemostasis.

[29]  S. C. Sharma,et al.  Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in juvenile-onset and maturity-onset diabetes mellitus. , 1981, Journal of clinical pathology.

[30]  L. Rand,et al.  Changes of fibrinolysis and factor VIII coagulant, antigen, and ristocetin cofactor in diabetes mellitus and atherosclerosis. , 1980, Thrombosis research.

[31]  H. Keen,et al.  Haemostatic variables associated with diabetes and its complications. , 1979, British medical journal.

[32]  E. Tsianos,et al.  Soluble Fibrin Complexes and Fibrinogen Heterogeneity in Diabetes Mellitus , 1979, Thrombosis and Haemostasis.

[33]  A. Teger‐Nilsson,et al.  Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. , 1977, Scandinavian journal of clinical and laboratory investigation.

[34]  S. Blix.  Studies on the fibrinolytic system in the euglobulin fraction of human plasma. A. Methodological study. B. Application of the methods. , 1961, Scandinavian journal of clinical and laboratory investigation.